Skip to main content

Special Announcement

Diabetes Risk Assessment Programme

 

Diabetes Risk Assessment Programme

One in every 10 people in Hong Kong has diabetes*. If not properly controlled, it will lead to chronic diabetic complications with serious consequences. Persistently high blood glucose levels destroy blood vessels and nerves, causing damage to multiple organs such as the eyes, brain, heart, kidneys, feet and more. People diagnosed with diabetes for 10 years or more have increased chance of dying from cancer especially in the presence of poor blood glucose control and other risk factors^.

Our Diabetes Risk Assessment Programme (the Programme) is fully supported by the Endocrinology & Diabetes Team of the Chinese University of Hong Kong (CUHK) and follows international guidelines where we use individualised data collected during structured assessment to issue a personalised report. The report includes risk categorisation, future risk of complications and personalised advice on medical therapies and self-management for people with diabetes through the evidence-based Joint Asia Diabetes Evaluation Program (JADE®) platform. The report also includes written recommendations by Specialists in Endocrinology, Diabetes & Metabolism and the report will be explained by experienced nurses, aimed at reducing the risks of hospitalisation and complications in people with diabetes.

*Diabetes Hongkong. From www.diabetes-hk.org/ch/page/認識糖尿病%20-%20流行情況 , retrieved 4-4-2022.
^Mao D et al. Risk associations of long-term HbA1c variability and obesity on cancer events and cancer-specific death in 15,286 patients with diabetes - A prospective cohort study. The Lancet Regional Health - Western Pacific. 2022;18:100315.
https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(21)00224-8/fulltext 

 

Programme Features

  • One-stop diabetes risk assessment service, recommended at diagnosis and every 12-18 months thereafter to reduce risks of hospitalisation and complications
  • Suitable for people with diabetes
  • Using the evidence-based JADE® platform to issue a personalised report to inform risk profiles, self-management and risk-based medical treatment  
  • Personalised report with written recommendations on risk management and treatment directions by Endocrinologists
  • Explanation of consolidated reports by experienced nurses
  • Supported by our multidisciplinary team including referral to our endocrinologists for consultations and regular follow up

 

Programme Details and Fee

Physical Examinations

  • Index of General Obesity - 1 Body Height & Weight

   (For calculation of Body Mass Index, BMI)

  • Index of Central Obesity - 2 Waist & Hip Circumference

   (For calculation of Waist Hip Ratio (WHR))

  • Blood Pressure
  • Medical, Family & Drug History Taking

Blood Tests

  • Fasting Blood Glucose
  • HbA1c
  • Liver Function
  • Renal Function
  • Full Lipid Profile

   (including Total Cholesterol, HDL-C, LDL-C, Triglycerides and Non-HDL Cholesterol)

  • Uric Acid
  • Calcium 
  • Adjusted Calcium 
  • Inorganic Phosphate
  • Complete Blood Count with Differential White Blood Count

Urine Test

  • Spot Urine Microalbumin
  • Spot Urine Creatinine
  • Urine Albumin to Creatinine Ratio

Cardiac Assessment

  • Resting Electrocardiogram

Eye Assessment

  • Vision Test
  • Fundus Photo

Foot Assessment

  • Peripheral Sensory & Vascular Tests

Explanation of report by experienced nurses

FEE (HKD)

$3,600

 

About the JADE® Programme

The JADE® Programme is an exemplary example of using data to transform diabetes care, a model advocated by global experts in the Lancet Commission on Diabetes.

 

Booking and Enquiry: 5172 1138

addressRoom 823, 8/F, CUHKMC